TAZORAC

This brand name is authorized in Canada, United States

Active ingredients

The drug TAZORAC contains one active pharmaceutical ingredient (API):

1 Tazarotene UNII 81BDR9Y8PS - TAZAROTENE

Tazarotene, a member of the acetylenic class of retinoids, is a prodrug which is converted to its active free form, tazarotenic acid, by de-esterification in the skin area. Tazarotenic acid is the only known metabolite of tazarotene to have retinoid activity. Read about Tazarotene

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TAZORAC Gel	FDA, National Drug Code (US)	MPI, US: SPL/PLR
TAZORAC Cream	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D05AX05	Tazarotene	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02230784, 02230785, 02243894, 02243895
Country: US	FDA, National Drug Code	Identifier(s): 0023-0042, 0023-8335, 0023-9155, 0023-9156, 16110-042, 16110-833, 16110-915, 16110-916